Will Nu Holdings report Q1 2026 revenue above $5.0B?
Current Prediction
Why This Question Matters
Revenue growth trajectory is the fundamental test of the ELEVATED expectations priced into $67.2B market cap. Q4 2025 revenue of $4.9B with 45% FX-neutral growth sets a high bar. Q1 revenue crossing $5B would demonstrate continued momentum despite the investment year. Missing $5B, especially with BRL depreciation reducing USD-reported figures, would test whether the market re-rates the multiple for deceleration.
Prediction Distribution
Individual Predictions(9 runs)
Q4 2025 revenue was $4.9B with 45% FX-neutral growth. Q1 2026 requires only ~2% QoQ growth to hit $5B. In BRL terms, the trajectory is strong — credit portfolio growing 40%, ARPAC growing 27%, customers growing 17M/year. The key uncertainty is FX: BRL depreciation could reduce the USD-reported number even if BRL revenue grows. Q1 may also have some LatAm financial seasonality. Management's investment year is cost-focused, not revenue-depressing. Leaning YES but FX creates genuine uncertainty.
The $5B threshold is a modest QoQ increase from $4.9B in BRL-constant terms. But this question is resolved on USD-reported revenue. Brazil's BRL has been volatile, and a 5-10% BRL depreciation would wipe out the QoQ growth in USD terms. The analysis notes revenue is presented FX-neutral at 45% growth — the USD number would be lower if BRL weakens. Without current FX data, this is genuinely uncertain. The underlying business momentum is strong, but FX makes the USD threshold a coin-flip.
Revenue drivers are all positive: credit portfolio at $32.7B growing 40%, ARPAC at $15 growing 27%, customers at 131M growing 13%. The question is whether USD-reported revenue crosses $5B. Q4 2025 delivered $4.9B. If BRL holds relatively stable, even modest growth crosses the threshold. Interest income on the growing credit portfolio and deposit float at high Selic rates provide strong revenue tailwinds. The 2026 investment year affects costs, not revenue. Moderate confidence in YES.
Strong lean toward YES. The business is growing 45% FX-neutral with ARPAC expanding 27% and credit portfolio up 40%. Q4 revenue was $4.9B. Only needs $100M QoQ increase. Even with moderate BRL weakness, the underlying growth rate is so strong it should overcome FX headwinds. High Selic boosts NIM and float income. Customer base continues expanding. The momentum is compelling.
Revenue momentum is strong but the FX factor is material. BRL has been under pressure from global dollar strength and EM volatility. A 3-5% BRL weakening from Q4 levels would be enough to keep USD revenue below $5B even with healthy BRL growth. The $5B threshold is psychologically important but the outcome depends significantly on FX movements that are outside management's control. Slightly above 50% but not high confidence.
The growth trajectory strongly supports exceeding $5B on a BRL-constant basis. Credit income is the largest revenue component, growing 40%+, and high Selic rates support the yield. ARPAC at $15 growing 27% on 131M customers provides another growth lever. The FX risk is real but BRL would need to depreciate meaningfully (>5%) from Q4 levels to prevent USD revenue from crossing $5B. More likely than not to clear the threshold.
Strong growth momentum. 45% FX-neutral growth. Only needs ~2% QoQ increase from $4.9B. FX is the wild card but underlying trajectory is very positive. Lean YES.
Business fundamentals strongly support growth. $5B is achievable if BRL holds. FX creates uncertainty. Moderate lean toward YES based on underlying momentum.
High Selic supporting interest income, ARPAC expanding, credit portfolio growing 40%. $100M QoQ increase is modest. FX is the main risk but BRL would need to decline significantly. Lean YES.
Resolution Criteria
Resolves YES if Nu Holdings reports Q1 2026 total revenue of $5.0B or more. Resolves NO if Q1 2026 revenue is below $5.0B. Revenue measured as reported in USD, not FX-neutral.
Resolution Source
Nu Holdings Q1 2026 earnings release or 6-K filing
Source Trigger
Revenue growth deceleration — testing whether 40%+ FX-neutral growth trajectory continues during investment year
Full multi-lens equity analysis